What is Roivant Sciences's switzerland — net operating losses?

Roivant Sciences (ROIV) reported switzerland — net operating losses of $1.51B in Q1 2026.

How has Roivant Sciences's switzerland — net operating losses changed year-over-year?

Roivant Sciences's switzerland — net operating losses decreased by 41.4% year-over-year, from $2.58B to $1.51B.

Switzerland — Net operating losses

Roivant Sciences Switzerland — Net operating losses decreased by 41.4% to $1.51B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 41.4%, from $2.58B to $1.51B.

Analysis

StatementSegment

First reportedQ4 2021

Last reportedQ4 2025May 20, 2026

Rolls up toNet Operating Loss Carryforwards

Metric ID: roiv_segment_switzerland_net_operating_losses

Historical Data

5 periods

	Q4 '21	Q4 '22	Q4 '23	Q4 '24	Q4 '25
Value	$1.75B	$2.63B	$3.44B	$2.58B	$1.51B
QoQ Change	—	+50.2%	+30.9%	-24.9%	-41.4%
YoY Change	—	+50.2%	+30.9%	-24.9%	-41.4%

Range$1.51B – $3.44B

CAGR-13.5%

Avg YoY Growth+3.7%

Median YoY Growth+3.0%

Current Streak2 quarters decline

Frequently Asked Questions

What is Roivant Sciences's switzerland — net operating losses?: Roivant Sciences (ROIV) reported switzerland — net operating losses of $1.51B in Q1 2026.
How has Roivant Sciences's switzerland — net operating losses changed year-over-year?: Roivant Sciences's switzerland — net operating losses decreased by 41.4% year-over-year, from $2.58B to $1.51B.